title: Trials show delayed recurrence in ovarian cancer.
abstract: Phase I trials of 2 treatments for recurrent ovarian cancer-a 2-step immunotherapy treatment and an antibody-drug conjugate-demonstrated promising early results in delaying recurrence, in work presented at the American Association for Cancer Research Annual Meeting 2013.
authors.forename: Eric
authors.initials: E
authors.lastname: Bender
mesh_terms: D019496:Cancer Vaccines / Q000627:therapeutic use; D000077216:Carcinoma, Ovarian Epithelial; D017321:Clinical Trials, Phase I as Topic; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009375:Neoplasms, Glandular and Epithelial / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000628:therapy*
chemical_list: D019496:Cancer Vaccines